|
|
Volumn 2, Issue , 2002, Pages 1-7
|
|
Oral sildenafil (Viagra™) in male erectile dysfunction: Use,efficacy and safety profile in an unselected cohort presenting to a Britishdistrict general hospital
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
SILDENAFIL;
CYCLIC GMP PHOSPHODIESTERASE;
PHOSPHODIESTERASE INHIBITOR;
PIPERAZINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIZZINESS;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
DYSPEPSIA;
ERECTILE DYSFUNCTION;
FLUSHING;
HEADACHE;
HEART PALPITATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NOSE CONGESTION;
PAIN;
PENIS;
PROSPECTIVE STUDY;
PUBLIC HOSPITAL;
QUESTIONNAIRE;
SIDE EFFECT;
THIRST;
TREATMENT FAILURE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
UNITED KINGDOM;
VISUAL DISORDER;
COITUS;
DRUG ANTAGONISM;
GENERAL HOSPITAL;
IMPOTENCE;
NATIONAL HEALTH SERVICE;
PATIENT SATISFACTION;
3',5'-CYCLIC-GMP PHOSPHODIESTERASE;
COITUS;
GREAT BRITAIN;
HOSPITALS, GENERAL;
HUMANS;
IMPOTENCE;
MALE;
PATIENT SATISFACTION;
PHOSPHODIESTERASE INHIBITORS;
PIPERAZINES;
PROSPECTIVE STUDIES;
STATE MEDICINE;
TREATMENT OUTCOME;
|
|
EID: 34248403280
PISSN: 14712490
EISSN: None
Source Type: Journal
DOI: 10.1186/1471-2490-2-4 Document Type: Article |
|
Times cited : (16)
|
|
References (13)
|
